Literature DB >> 24406928

NIH inventions translate into drugs and biologics with high public health impact.

Sabarni K Chatterjee1, Mark L Rohrbaugh1.   

Abstract

Mesh：

Year:  2014        PMID： 24406928     DOI： 10.1038/nbt.2785

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  10 in total

Review 1.  The importance of new companies for drug discovery: origins of a decade of new drugs.

Authors:  Robert Kneller
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

2.  Financial anatomy of biomedical research.

Authors:  Hamilton Moses; E Ray Dorsey; David H M Matheson; Samuel O Thier
Journal:  JAMA       Date:  2005-09-21       Impact factor: 56.272

3.  The licensing of DNA patents by US academic institutions: an empirical survey.

Authors:  Lori Pressman; Richard Burgess; Robert M Cook-Deegan; Stephen J McCormack; Io Nami-Wolk; Melissa Soucy; LeRoy Walters
Journal:  Nat Biotechnol       Date:  2006-01       Impact factor: 54.908

4.  Academic patents and access to medicines in developing countries.

Authors:  Bhaven N Sampat
Journal:  Am J Public Health       Date:  2008-11-13       Impact factor: 9.308

5.  The role of public-sector research in the discovery of drugs and vaccines.

Authors:  Ashley J Stevens; Jonathan J Jensen; Katrine Wyller; Patrick C Kilgore; Sabarni Chatterjee; Mark L Rohrbaugh
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

6.  What are the respective roles of the public and private sectors in pharmaceutical innovation?

Authors:  Bhaven N Sampat; Frank R Lichtenberg
Journal:  Health Aff (Millwood)       Date:  2011-02       Impact factor: 6.301

Review 7.  An empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequences.

Authors:  Aaron S Kesselheim
Journal:  Milbank Q       Date:  2011-09       Impact factor: 4.911

8.  Private sector contributions to pharmaceutical science: thirty-five summary case histories.

Authors:  Benjamin Zycher; Joseph A DiMasi; Christopher-Paul Milne
Journal:  Am J Ther       Date:  2010 Jan-Feb       Impact factor: 2.688

Review 9.  The cost of drug development: a systematic review.

Authors:  Steve Morgan; Paul Grootendorst; Joel Lexchin; Colleen Cunningham; Devon Greyson
Journal:  Health Policy       Date:  2011-01-21       Impact factor: 2.980

10.  Funding of US biomedical research, 2003-2008.

Authors:  E Ray Dorsey; Jason de Roulet; Joel P Thompson; Jason I Reminick; Ashley Thai; Zachary White-Stellato; Christopher A Beck; Benjamin P George; Hamilton Moses
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272
  10 in total
  4 in total

1.  Surgery investigators funded through the National Institutes of Health: A rebirth.

Authors:  Yinin Hu; Brandy L Edwards; Kevin Hu; Kendall D Brooks; Craig L Slingluff
Journal:  Surgery       Date:  2017-02-01       Impact factor: 3.982

2.  Examining the Predictive Validity of NIH Peer Review Scores.

Authors:  Mark D Lindner; Richard K Nakamura
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

3.  Facilitating public and patient involvement in basic and preclinical health research.

Authors:  James Maccarthy; Suzanne Guerin; Anthony G Wilson; Emma R Dorris
Journal:  PLoS One       Date:  2019-05-14       Impact factor: 3.240

4.  Public-private knowledge transfer and access to medicines: a systematic review and qualitative study of perceptions and roles of scientists involved in HPV vaccine research.

Authors:  Rosa Jahn; Olaf Müller; Stefan Nöst; Kayvan Bozorgmehr
Journal:  Global Health       Date:  2020-03-05       Impact factor: 4.185
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.